Shandong Sanyuan Biotechnology Co.,Ltd.

301206

CNE100005774

Shandong Sanyuan Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of new sweetener products. The Company's main products are erythritol and compound sugar. The compound sugar products include momordica grosvenori compound sugar, stevia compound sugar, sucralose compound sugar and others. The Company's products are sold to America, Europe, Africa, Oceania and other regions.

Employees

427

Sector

Food Processing

Calendar

2024-10-23 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

23.45CNY

Average target price

32.00CNY

Spread / Average Target

+36.46%

Consensus

Profit revisions

Estimate revisions

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-18			5-day change	1st Jan Change
23.45 ^CNY	-1.88%		-5.18%	-18.80%

Aug. 30	Shandong Sanyuan Biotechnology Co.,Ltd. Proposes Interim Dividend for the First Half of 2024	CI
Aug. 29	Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Shandong Sanyuan Biotechnology Co.,Ltd. Proposes Interim Dividend for the First Half of 2024	Aug. 30	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 29	CI
Sanyuan Biotech to Boost Supplies of Other Sugar Substitutes Following EU Additional Duties	Jul. 23	MT
Shandong Sanyuan Biotechnology Co.,Ltd. Announces Board Appointments	Jul. 22	CI
Sanyuan Biotechnology Completes Construction of Allulose Plant	Jul. 09	MT
Shandong Sanyuan Biotechnology Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	Jul. 08	CI
Shandong Sanyuan Biotechnology Co.,Ltd. authorizes a Buyback Plan.	Jul. 07	CI
Sanyuan Preparing to Appeal EU Plan to Impose Tariffs on China-Made Sweeteners	Jul. 02	MT
Shandong Sanyuan Biotechnology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 29 May 2024	May. 21	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.	Feb. 09	CI
EU Opens Anti-Dumping Probe Into Sanyuan Biotechnology’s Erythritol Products	Nov. 28	MT
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18	CI
Shandong Sanyuan Biotechnology Co.,Ltd.(XSEC:301206) added to S&P Global BMI Index	23-09-18	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Implements Final Profit Distribution Plan (A Shares) for 2022, Payable on 21 June 2023	23-06-14	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-19	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Proposal Final Cash Dividend for 2022	23-04-27	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Hapioneer announced that it has received $8.200000 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd. and other investors.	22-10-24	CI
Shandong Peixue Bioengineering Co., Ltd. announced that it expects to receive CNY 60 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd.	22-10-22	CI

Shandong Sanyuan Biotechnology Co.,Ltd.

Equities